Kaleida Health, Olean General Open New Cardiac Lab
Gary Maur, MD, and Chris Mallavarapu, MD, the new interventional cardiologists working at OGH, saw three scheduled angiogram procedures and a middle-of-the-night emergency case. All procedures were successfully performed and the four patients are doing well.
“When we say our goal is to take what we have today – which is very good – and make it better for those we serve, this is exactly what we are talking about,” said James R, Kaskie, president and CEO of Kaleida Health. “The hub and spoke model of health care – like our partnership with Olean General - is improving access for cardiac patients, improving quality of care and saving lives.”
The new lab is operated in partnership between OGH and Kaleida Health’s Gates Vascular Institute (GVI), upstate New York’s largest provider of cardiac care.
With the opening of the new lab, patients in the region have access to cardiac catheterization procedures and interventions to quickly diagnose and treat coronary artery disease, significantly reducing both time and distance for residents to travel to receive life-saving heart care. OGH is the only hospital in Southwestern New York to have these capabilities.
“What is so exciting about this new clinical capability at OGH is that it will absolutely and positively save the lives of many heart attack victims,” said Timothy J. Finan, president and CEO of Olean General Hospital and Upper Allegheny Health System.
Cardiac catheterization is a medical procedure where physicians insert a long, thin, flexible tube called a catheter into a blood vessel in the arm, groin (upper thigh), or neck and thread it to the heart. Through the catheter, doctors can do diagnostic tests and treatments on the heart.
Procedures available at the new catheterization lab include angiography, used to diagnose blood vessel blockage around the heart, and cardiac intervention, used to repair blocked arteries using balloon angioplasty and stent placement.
Kaleida Health hired Drs. Maur and Mallavarapu and relocated a complete cardiac catheterization laboratory to OGH from the GVI in Buffalo.
Kaleida Health’s cardiac program at the GVI accounts for 8,000 catheterization procedures and nearly 1,000 heart surgeries each year in Western New York. It has been rated in the top 10 percent for heart surgery and among the top 5% in the nation for coronary angioplasty.
Kaleida Health’s cardiac program has been named a BlueCross BlueShield “distinction center” for cardiac care in Western New York and has received a HealthGrades Five Star award, the United Healthcare Cardiac Center of Excellence award and the Premier award for Quality for Coronary Artery Bypass Surgery.